BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15994429)

  • 41. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
    Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
    Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
    Samanta A; Qian X; Greene MI
    DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation.
    Hu X; Herrero C; Li WP; Antoniv TT; Falck-Pedersen E; Koch AE; Woods JM; Haines GK; Ivashkiv LB
    Nat Immunol; 2002 Sep; 3(9):859-66. PubMed ID: 12172544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence Supporting a Lymphatic Endothelium Origin for Angiomyolipoma, a TSC2(-) Tumor Related to Lymphangioleiomyomatosis.
    Yue M; Pacheco G; Cheng T; Li J; Wang Y; Henske EP; Schuger L
    Am J Pathol; 2016 Jul; 186(7):1825-1836. PubMed ID: 27289491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis.
    Flavin RJ; Cook J; Fiorentino M; Bailey D; Brown M; Loda MF
    Am J Clin Pathol; 2011 May; 135(5):776-82. PubMed ID: 21502434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulmonary lymphangioleiomyomatosis and renal angiomyolipoma in a patient with systemic lupus erythematosus: A case report.
    Koh JS; Oh S; Chung C
    Medicine (Baltimore); 2022 Sep; 101(38):e30554. PubMed ID: 36197220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways.
    Yu J; Astrinidis A; Howard S; Henske EP
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L694-700. PubMed ID: 12922981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TSC2 Interacts with HDLBP/Vigilin and Regulates Stress Granule Formation.
    Kosmas K; Filippakis H; Khabibullin D; Turkiewicz M; Lam HC; Yu J; Kedersha NL; Anderson PJ; Henske EP
    Mol Cancer Res; 2021 Aug; 19(8):1389-1397. PubMed ID: 33888601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells.
    Himes BE; Obraztsova K; Lian L; Shumyatcher M; Rue R; Atochina-Vasserman EN; Hur SK; Bartolomei MS; Evans JF; Krymskaya VP
    PLoS One; 2018; 13(5):e0197105. PubMed ID: 29758070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis.
    Tyryshkin A; Bhattacharya A; Eissa NT
    Cancer Res; 2014 Apr; 74(7):1996-2005. PubMed ID: 24691995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical features of lymphangioleiomyomatosis complicated by renal angiomyolipomas.
    Mizushina Y; Bando M; Hosono T; Mato N; Nakaya T; Ishii Y; Yamasawa H; Sugiyama Y
    Intern Med; 2011; 50(4):285-9. PubMed ID: 21325759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Prolactin Receptors in Lymphangioleiomyomatosis.
    Alkharusi A; Lesma E; Ancona S; Chiaramonte E; Nyström T; Gorio A; Norstedt G
    PLoS One; 2016; 11(1):e0146653. PubMed ID: 26765535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coexistence of pulmonary lymphangioleiomyomatosis and pulmonary angiomyolipoma.
    Sun X; Feng R; Zhang Y; Shi J; Xu KF
    BMC Pulm Med; 2016 Aug; 16(1):120. PubMed ID: 27527652
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal angiomyolipoma in association with pulmonary lymphangioleiomyomatosis.
    De Pauw RA; Boelaert JR; Haenebalcke CW; Matthys EG; Schurgers MS; De Vriese AS
    Am J Kidney Dis; 2003 Apr; 41(4):877-83. PubMed ID: 12666075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No evidence for genetic linkage between development of multiple sclerosis and components of the IFN system and the JAK-STAT pathway.
    Bergkvist M; Olsson M; Sandberg-Wollheim M
    Mult Scler; 2004 Feb; 10(1):87-8. PubMed ID: 14760959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tyrosine Kinase Inhibitors Diminish Renal Neoplasms in a Tuberous Sclerosis Model Via Induction of Apoptosis.
    Unachukwu U; Sonett J; Woode D; Shiomi T; Chada K; D'Armiento JM
    Mol Cancer Ther; 2023 Jul; 22(7):844-858. PubMed ID: 37127876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures.
    Karbowniczek M; Yu J; Henske EP
    Am J Pathol; 2003 Feb; 162(2):491-500. PubMed ID: 12547707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Notch transactivates Rheb to maintain the multipotency of TSC-null cells.
    Cho JH; Patel B; Bonala S; Manne S; Zhou Y; Vadrevu SK; Patel J; Peronaci M; Ghouse S; Henske EP; Roegiers F; Giannikou K; Kwiatkowski DJ; Mansouri H; Markiewski MM; White B; Karbowniczek M
    Nat Commun; 2017 Nov; 8(1):1848. PubMed ID: 29184052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Case of Tuberous Sclerosis Complex with Lymphangioleiomyomatosis and Renal Cell Carcinoma.
    Wu Y; Li H; Yu X; Lin M; Chen Y
    Onco Targets Ther; 2020; 13():12421-12426. PubMed ID: 33293833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pulmonary lymphangioleiomyomatosis: From pathogenesis to management].
    Chebib N; Khouatra C; Lazor R; Archer F; Leroux C; Gamondes D; Thivolet-Bejui F; Cordier JF; Cottin V
    Rev Mal Respir; 2016 Oct; 33(8):718-734. PubMed ID: 26604019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.